Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

GoodRx

Biotech & Life Sciences · Santa Monica, United States · Founded 2011 · IPO 2020 Unicorn

Provides health consumers with convenient and affordable prescription drugs

Valuation
$1.08B
Market cap · May/2026
Revenue
$797M
Latest reported FY
EBITDA
$236M
Latest reported FY

Investors

12 investors on GoodRx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Global footprint

Where GoodRx has talent and traffic

AI talent share
3.0% of workforce is AI talent
(33 of 1,093 staff)
Core AI50.46%
Other AI282.56%
Non-AI workforce1,06096.98%
Workforce by country
20 countries with
team presence
🇺🇸 United States95.7%
🇮🇳 India0.8%
🇧🇷 Brazil0.8%
🇵🇱 Poland0.2%
🇫🇷 France0.1%
Top 5 of 20 shown
Web traffic by country
21M monthly visits
across markets
🇺🇸 United States84.9%
🇨🇦 Canada3.4%
🇦🇺 Australia1.8%
🇮🇳 India1.8%
🇵🇭 Philippines0.7%
Top 5 markets shown

Patent intelligence

$340k patent portfolio · 3 active families

Estimated portfolio value
$340k
0.03% of market cap · 1.8× smaller than top peer Omada Health ($612k)
3 active patent families
Where GoodRx innovates DatabaseDrug productPharmacyDrug pricesIdentifying medications

Where GoodRx concentrates vs peers

Each axis is a top-10 topic across GoodRx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

GoodRx's 7 investments and acquisitions.

Every disclosed deal where GoodRx appeared as a backer or acquirer, 2012–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across GoodRx's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        GoodRx's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        What the market is saying about GoodRx

        An AI-synthesized read of the highest-engagement posts about GoodRx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See GoodRx on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.